Figure 1

Sharpen your clinical knowledge. Join 3 million HCPs using Figure 1 to share and discuss medical cases. Download the app or visit

[Figure 1 @Figure1]

With over 100,000 real patient cases and 3 million members, Figure 1 is changing the future of #MedicalEducation.

Join the largest global community of medical minds and start collaborating: https://t.co/T6uPB618UC

[Figure 1 @Figure1]

Heart Health Quiz Challenge 🫀

A 53-year-old woman is newly diagnosed with hypertension — her recent labs are all normal. What additional testing should be ordered?

Take the full quiz on the Figure 1 app: https://t.co/g2S89NrFBJ

#Hypertension #HeartHealth #MedEd #MedTwitter

[Figure 1 @Figure1]

Dr. Steve Feldman shares how treatment-resistant scalp psoriasis is often not a matter of medication efficacy, but patient adherence.

Watch the new video on Figure 1: https://t.co/GLBUJyqzpc

#Psoriasis #Dermatology #MedEd #MedTwitter #ClinicalLearning #PatientCare

[Figure 1 @Figure1]

What’s your first step in treating this patient with morphea profunda? Create a treatment plan for this patient and see how it compares to the real case on the Figure 1 app: https://t.co/i1D3N3cJTE

#MedicalEd #MorpheaProfunda #ClinicalLearning #PatientCare #MedTwitter

[Figure 1 @Figure1]

ELCC 2026 is coming — Copenhagen, March 25–28 🫁

Follow our dedicated ELCC 2026 profile on the Figure 1 app for expert insights as they happen: https://t.co/t5cz5gShUq

#ELCC26 #esmomeetings #LungCancer #ThoracicOncology #LungCancerResearch

[Figure 1 @Figure1]

Save the date: Oncology Forum returns May 31 in Chicago

After ASCO’s plenary and key data, join focused, expert‑led discussions to unpack what matters and what to do next. Step off the floor and talk it through with peers.

Learn more: https://t.co/utxprmjL89

#OncForum2026

[Figure 1 @Figure1]

Big news! DDx has been named one of @FeedSpot's Top 100 Doctor Podcasts AND a Top 45 Canadian Doctor Podcast 🏆 Thank you to our incredible community of listeners!

Catch up on all 12 seasons here: https://t.co/pA09khAq4z

#MedTwitter #MedicalPodcast #MedEd #ClinicalLearning

[Figure 1 @Figure1]

Introducing the Community Tab in Figure 1 🩺

✅ Accounts to Follow
✅ Your Groups
✅ Interactive Case Labs Debates
✅ Public Groups
✅ Expert Feeds from real doctors

Update the app & check it out.

#MedTwitter #MedEd #ClinicalLearning #PatientCare

[Figure 1 @Figure1]

Can one diabetic patient change how you treat GCA? @ebrheum shares the case that shifted his thinking on steroids → short tapers + steroid-sparing therapy.

Watch: https://t.co/gRQjLYx7Hc

#GiantCellArteritis #MedEd #MedTwitter #Rheumatology

[Figure 1 @Figure1]

Recent FDA rejections of several therapies for rare diseases have drawn criticism that argues that regulatory expectations may be becoming more difficult to meet. Is the current regulatory framework well-suited for rare disease drug development? Let us know.

#RareDisease #FDA

[Figure 1 @Figure1]

ACC.26 is coming — New Orleans, March 28–30 🫀

Follow our dedicated profile on the Figure 1 app to be notified when expert insights on the latest advances in cardiovascular medicine are live: https://t.co/bDwoI58fdq

#ACC26 #Cardiology #MedEd #MedicalConference #HeartHealth

[Figure 1 @Figure1]

A painful, pruritic red plaque with erosions on the lower leg. What's your next move? Create a treatment plan for this patient and see how it compares to the real case.

Take the challenge on the Figure 1 app: https://t.co/E7efcq7eMh

#MedEd #VenousStasis #VascularMedicine

[Figure 1 @Figure1]

28M, >10 bloody stools/day, spontaneous bleeding, frank ulceration, complete loss of vascular pattern.

What’s the Mayo Endoscopic Score?

See how you did & take the full quiz on the Figure 1 app: https://t.co/32pT9y2UgP

#MedEd #IBD #GITwitter #UlcerativeColitis

[Figure 1 @Figure1]

@BGarmezy and @mkbupathi of @OncologyDecoded are wrapping up their moderation period.

Ask your question or share your take on BRCA2-mutated mHSPC before it's too late: https://t.co/W9T6n3LKOm

#Oncology #ProstateCancer

[Figure 1 @Figure1]

Is it time for rheumatologists to prescribe GLP1’s?

New data hints at better disease control in rheumatic conditions, and @ebrheum discusses whether it's time for rheumatologists to start prescribing them.

Read here: https://t.co/LfUG8CHIah

#Rheumatology #GLP1 #MedTwitter

[Figure 1 @Figure1]

Introducing Case Labs.

Our first case explores treatment decision-making in BRCA2-mutated metastatic hormone-sensitive prostate cancer, led by @BGarmezy and @mkbupathi of @OncologyDecoded

Join the debate and engage with experts for the next 30 days: https://t.co/Nlz6OJ9e4c

[Figure 1 @Figure1]

Watch @AmitGoyalMD, co-founder of @CardioNerds, break down a case where OCT confirmed acute plaque rupture—and why biomarkers didn’t tell the full story.

Watch the full video: https://t.co/wg2rOk2h37

#Cardiology #UnstableAngina #MedEd

[Figure 1 @Figure1]

Pruritic plaques. Insect bites. Eosinophils on biopsy. What’s your treatment plan?

Take the treatment challenge and compare your approach to the real case.

https://t.co/7Cfuwm2VOf

#DermTwitter #MedEd #Dermatology

[Figure 1 @Figure1]

The final @Uromigos Year in Review episode is live — recapping 2025 bladder cancer advances, from ADCs and EV+pembro to CTDNA in risk assessment & treatment response. Listen now: https://t.co/cYDOVNav2K

[Figure 1 @Figure1]

Episode 2 of the @Uromigos Year in Review series is live. Reviewing prostate cancer developments from 2025, focusing on personalized therapy in the mHSPC setting, including PARP inhibitors, radioligands, AKT inhibitors, and ARPI use in high-risk disease. https://t.co/3oj4AzbsBD

[Figure 1 @Figure1]

Our friends @Uromigos have a Year in Review podcast series on key renal oncology updates from 2025. Episode 1 covers RCC highlights, clinical debates, and what's coming next. Listen now: https://t.co/spw1Hw9yel